// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Fat Mass and Obesity-Associated rs9939609 Gene Variant Is Related to Fasting Glucose in Children with Mental Health Conditions

ALEJANDRA M. WIEDEMAN - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Attention deficit hyperactivity disorder

N/A

Time Spent in Glycaemic Ranges and Carbohydrate Intake during Cycling in Professional Cyclists with Type 1 Diabetes

OLIVIA MCCARTHY - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 1 diabetes mellitus

N/A

Associations of Maximum Physiological Performance and Diabetes in a Group of World Class Road Cyclists with Type 1 Diabetes

MAX L. ECKSTEIN - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 1 diabetes mellitus

N/A

Greater Time Spent in Hypoglycemia during Night Compared with Day during Intensified Training in Professional Cyclists with Type 1 Diabetes—A Prospective Observational Study

OTHMAR MOSER - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Hypothalamic Glucocorticoid Action Regulates Lipid Metabolism

MIGUEL CARDOSO - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dyslipidemia

Glucocorticoid

Post Hoc Analysis from EMPA-REG OUTCOME

SILVIO E. INZUCCHI - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

BI-10773

Somatostatin Receptor 2 Antagonism Enhances Plasma Glucagon Levels during Insulin-Induced Hypoglycemia in a Rodent Model of Type 2 Diabetes Mellitus

MEHRAN NEJAD-MANSOURI - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

Streptozotocin

JNK1 Plays a Causal Role in Palmitate-induced ß-Cell Dysfunction In Vivo

JUSTIN HOU MING YUNG - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Palmitic acid

Early-Onset Type 2 DM in Young and Middle-Aged Adults in a Diabetes Clinic

KAJANA SUNTHARAMOORTHY - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Diabetes

N/A

Demographics of Women with Type 1 Diabetes Attending a Diabetes and Pregnancy Clinic, 2000-2002, 2010-2012, and 2014-2016

PARUL KHANNA - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 1 diabetes mellitus

N/A

High-Risk of Metabolic Syndrome after Delivery in Pregnancies Complicated by Gestational Diabetes

GANG HU - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Gestational Diabetes

N/A

Demographics of Women with Type 2 Diabetes Attending a Diabetes and Pregnancy Clinic, 2000-2002, 2010-2012, and 2014-2016

LINDSEY CHOW - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

Metformin Hydrochloride

2000-2002, 2010-2012, and 2014-2016

PARUL KHANNA - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Infertility

N/A

A Qualitative Study

EMILY J. HAYNES - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 1 diabetes mellitus

N/A

Real-World Risk Indicators of Impaired Awareness of Hypoglycemia in T2DM (InHypo-DM Study)

ALEXANDRIA RATZKI-LEEWING - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Diabetes

N/A

Interest among T1D and T2D Patients Taking Insulin in Adding a New Drug Therapy to Prevent Nocturnal Hypoglycemia

RICHARD LIGGINS - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hyperglycemia

N/A

HB-EGF Signaling Is Required for Glucose-Induced Pancreatic ß-Cell Proliferation in Rats

HASNA MAACHI - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Mice Fed a Low Protein Diet In Utero Show Decreased Apelin Receptor Presence in Ins+Glut2Lo Cells during Pregnancy Associated with Lower ß-Cell Mass

HOUSHANG AZIMI - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Beta-Cell Compensation to Pubertal Insulin Resistance Is Compromised in High-Fat Fed Rats and Impairs Glucose Homeostasis Later in Life

ANNE-LAURE CASTELL - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

hGH

Exploring the Role of Autophagy in Pancreatic Alpha Cells

MIWA HIMURO - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Intranasal glucagon

Copyright © 2026. QuantiNova All rights reserved